You can buy or sell MCRB and other stocks, options, ETFs, and crypto commission-free!
Seres Therapeutics, Inc. operates a microbiome therapeutics platform company, which engages in the development of biological drugs. The firm creates medicines using live bacteria to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. Read More It focuses on implementing microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. The company was founded by Geoffrey von Maltzahn, David A. Berry and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.
52 Week High
52 Week Low
Yahoo FinanceMay 4
Edited Transcript of MCRB earnings conference call or presentation 2-May-19 12:30pm GMT
Q1 2019 Seres Therapeutics Inc Earnings Call Cambridge May 4, 2019 (Thomson StreetEvents) -- Edited Transcript of Seres Therapeutics Inc earnings conference call or presentation Thursday, May 2, 2019 at 12:30:00pm GMT TEXT version of Transcript ================================================================================ Corporate Participants ================================================================================ * Carlo Tanzi Seres Therapeutics, Inc. - VP of IR & Corporate Communication...
-$0.38 per share
-$0.59 per share